The Lysosomal & Rare Disorders Research & Treatment Center was founded in 2013 by Dr. Ozlem Goker-Alpan with a vision to provide high-quality care for individuals with lysosomal storage diseases and other rare genetic disorders.

Dr. Goker-Alpan is a world-renowned authority in lysosomal and other rare genetic disorders. She is well known for her over 20 years of dedication to the health and well-being of her patients.


Mission and Vision

Established in 2013 by Dr. Ozlem Goker-Alpan, the Lysosomal & Rare Disorders Research & Treatment Center stands at the leading edge of clinical research for Lysosomal diseases and other rare genetic disorders. Dr. Goker-Alpan, a globally recognized expert in the field of Lysosomal disorders, brings more than two decades of committed service to health and wellness of patients with Rare diseases. Our center is dedicated to delivering exceptional care and advancing knowledge in these specialized areas.

Our goal at the LDRTC is to be at the forefront for understanding and treating Lysosomal and other rare diseases. We focus on understanding different pathways involved in these disorders, finding new ways to assess them, and developing better treatments.

At LDRTC, our vision is to create a future where Lysosomal disorders are no longer a daunting challenge for patients, families and physicians. We aim to be one of the leaders in developing groundbreaking treatments and offering comprehensive care. Our goal is to enhance the quality of life for those affected by these disorders, ensuring they have access to the latest advancements in medical care. We are dedicated to empowering patients and their families with knowledge and hope, paving the way towards a life full of possibilities despite the challenges of lysosomal disorders.

By doing so, we pledge to provide complete medical care and support to people with these diseases from all over, both in our country and internationally. Our center offers an extensive platform for patients and their families as they navigate the complexities of these conditions.